Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome.

Kaakati, Rayan; Khokhar, Dilawar; Akin, Cem

Kaakati, Rayan; Khokhar, Dilawar; Akin, Cem.

Afiliação

Kaakati R; Department of Internal Medicine, University of Michigan, Ann Arbor, Mich.
Khokhar D; Department of Internal Medicine, Allergy Immunology, University of Michigan, Ann Arbor, Mich.
Akin C; Department of Internal Medicine, Allergy Immunology, University of Michigan, Ann Arbor, Mich. Electronic address: cemakin@med.umich.edu.

J Allergy Clin Immunol Pract ; 9(8): 3198-3199, 2021 08.

Article em En | MEDLINE | ID: mdl-34033981

Assuntos

COVID-19; Mastocitose; Vacinas contra COVID-19; Humanos; Mastócitos; Mastocitose/diagnóstico; SARS-CoV-2; Vacinação

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mastocitose / COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google